IBEX Technologies Inc.
IBT
Clasificación en acciones
#28781
Founded in 1972 and based in Montreal, Canada, IBEX Technologies Inc.... Founded in 1972 and based in Montreal, Canada, IBEX Technologies Inc. specializes in the production and global distribution of enzymes tailored for biomedical applications. The company's reach extends to Canada, the United States, Germany, and the United Kingdom, as well as other international markets. Its extensive product catalog features recombinant glycosaminoglycan lyases, such as Heparinase I, II, and III, along with Chondroitinase AC and B. Furthermore, IBEX offers collagen ELISAs designed to investigate the synthesis and breakdown of connective tissue components, complementing these with collagen antibodies and diamine oxidase liquid. They are also a key provider of arthritis assays, essential for research into osteoarthritis. Beyond their product lines, IBEX delivers lyophilization services for disposable medical device parts, in addition to custom fermentation and contract manufacturing capabilities. Their diverse client base encompasses medical device fabricators, quality control facilities, producers of low molecular weight heparin, and academic research institutions.
Precio por acción
$1.05
Última sincronización: 2024-04-11
Capitalización bursátil
$23.31M
Cambio (1 día)
-0.01%
Cambio (1 año)
5.21%
País
CA
Comercio IBEX Technologies Inc. (IBT)
Categoría
Healthcare
Ingresos de IBEX Technologies Inc. (IBT)
Ingresos en Oct 2026 TTM: 0
Según los últimos informes financieros de IBEX Technologies Inc., los ingresos actuales de la empresa (TTM) son 0. En 2026, la empresa obtuvo unos ingresos de 0 igual a los ingresos del año 2026, que fueron de 0. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de IBEX Technologies Inc. desde 2026 hasta 2026
Ingresos al final de cada año
| Año | Ingresos | Cambiar |
|---|---|---|
| Not enough data for the provided dates. | ||
Ingresos de empresas similares o competidoras
| Empresa | Ingresos | Diferencia de ingresos | País |
|---|---|---|---|
| $12.62B | - |
US
|
|
| $2.23B | - |
US
|
|
| $15.74B | - |
AU
|
|
| $6.02B | - |
NL
|
|
| - | - |
CH
|
